MedPath

Assistance Publique des Hôpitaux de Paris SA

Assistance Publique des Hôpitaux de Paris SA logo
🇫🇷France
Ownership
Private
Established
1849-01-01
Employees
10K
Market Cap
-
Website
http://www.aphp.fr

A Rehabilitation Program Based on Daily Activities in Patients With Cerebrovascular Accident

Not Applicable
Not yet recruiting
Conditions
Stroke
Interventions
Other: Personalized program of rehabilitation
Other: Routine program of rehabilitation
First Posted Date
2023-03-16
Last Posted Date
2024-01-31
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Target Recruit Count
158
Registration Number
NCT05772663
Locations
🇫🇷

New Technilogy Platform department, Raymond Poincaré hospital - APHP, Garches, France

3D Modeling of the Cervico-facial Region and Cranial Nerve Tractography: IMAG 2 ORL Project

Not Applicable
Recruiting
Conditions
Congenital Abnormalities
Head and Neck Neoplasms
Interventions
Other: Tractography MRI
First Posted Date
2023-03-10
Last Posted Date
2024-08-13
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Target Recruit Count
20
Registration Number
NCT05763615
Locations
🇫🇷

Hôpital Necker-Enfants Malades, Paris, France

DAPAgliflozine to Attenuate Cardiac RemOdeling afTEr aCuTe myOcardial Infarction

Phase 3
Recruiting
Conditions
NSTEMI
Left Ventricular Dysfunction
AMI
STEMI
Interventions
First Posted Date
2023-03-10
Last Posted Date
2024-04-04
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Target Recruit Count
450
Registration Number
NCT05764057
Locations
🇫🇷

Department of Cardiology AP-HP Hôpital européen Georges - Pompidou, Paris, France

Ruxolitinib as First Line Treatment in Primary Haemophagocytic Lymphohistiocytosis (R-HLH)

Phase 2
Not yet recruiting
Conditions
Haemophagocytic Lymphohistiocytosis
Interventions
First Posted Date
2023-03-09
Last Posted Date
2024-01-09
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Target Recruit Count
20
Registration Number
NCT05762640

Respiratory Variability and Dyspnea During Spontaneous Breathing Trial

Completed
Conditions
Relationship Between Dyspnea and Ventilatory Variability
Interventions
Other: Dyspnea assessment
First Posted Date
2023-03-09
Last Posted Date
2024-07-19
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Target Recruit Count
42
Registration Number
NCT05762614
Locations
🇫🇷

Hôpital Pitié-Salpêtrière, Paris, France

Severe Eosinophilic Asthma Phenotypes During Childhood Have Various Origins

Not yet recruiting
Conditions
Asthma in Children
Severe Asthma
First Posted Date
2023-03-09
Last Posted Date
2023-03-09
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Target Recruit Count
360
Registration Number
NCT05762627
Locations
🇫🇷

Allergy Department, Trousseau Hospital, Paris, France

Evaluation of the Use of a Remote Monitoring and Follow-up Option for Patients With Chronic Obstructive Pulmonary Disease (BOREAL)

Not Applicable
Recruiting
Conditions
Chronic Obstructive Pulmonary Disease
First Posted Date
2023-03-08
Last Posted Date
2024-01-09
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Target Recruit Count
150
Registration Number
NCT05759247
Locations
🇫🇷

Pneumology Department - Hôpital Cochin, Paris, France

Positioning of Molecular Markers in Clinical Routine for the Management of Patients With Adrenal Cancers/Tumors (COMETE-CARE)

Not Applicable
Recruiting
Conditions
Cancer
Adrenal
Interventions
Other: Blood sample
Other: Urine sample
Other: Tumor sample
First Posted Date
2023-03-06
Last Posted Date
2024-01-09
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Target Recruit Count
450
Registration Number
NCT05754892
Locations
🇫🇷

GH Paris Centre, Assistance Publique - Hôpitaux de Paris, Paris, France

Cognitive Processing Slowness as a Marker of Cognitive Impairment in Non-central Nervous System Cancer Patients

Not yet recruiting
Conditions
Colon Cancer
Cognitive Impairment
Breast Cancer
Interventions
Other: Saint-Louis Lille Battery (SSLIB)
First Posted Date
2023-03-03
Last Posted Date
2023-03-08
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Target Recruit Count
200
Registration Number
NCT05754060

Immunogenicity and Reactogenicity of the Beta-variant Recombinant Protein Booster Vaccine (VidPrevtyn Beta, Sanofi) Compared to a Bivalent mRNA Vaccine (Comirnaty Original/Omicron BA.4-5, BioNTech-Pfizer) in Adults Previously Vaccinated With at Least 3 Doses of COVID-19 mRNA Vaccine

Phase 3
Active, not recruiting
Conditions
Vaccine Reaction
COVID-19
Interventions
Biological: VidPrevtyn® Beta vaccine (Sanofi/GSK)
Biological: Comirnaty® BNT162b2 /Omicron BA.4-5 vaccine (Pfizer-BioNTech)
First Posted Date
2023-03-01
Last Posted Date
2023-06-29
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Target Recruit Count
248
Registration Number
NCT05749926
Locations
🇫🇷

CIC 1417 Cochin-Pasteur, Paris, France

© Copyright 2025. All Rights Reserved by MedPath